Current intraoperative therapeutic delivery strategies are limited. Drs. Young, de Groot, and Berger are developing a first-of-kind intraoperative focused ultrasound device that can be applied directly to the brain during brain tumor surgeries and improve the delivery of therapeutic agents through the blood brain barrier to regions of residual tumor cells that cannot be safely removed.
